Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Group National Diabetes Data.
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
Diabetes, 28 (1979), pp. 1039-1057
[2.]
World Health Organization.
Diabetes mellitus: report of a WHO Study Group, pp. 727
[3.]
J.J. Hoett, B.B. Tripathy, R.H. Rao, C.S. Yajnik.
Malnutrition and diabetes in the tropics.
Diabetes Care, 19 (1996), pp. 1014-1017
[4.]
J. Lu, Q. Li, H. Xie, Z. Chen, A.E. Borovitskaya, Maclaren, et al.
Identification of a second transmembrane protein tyroxine phophatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment.
Proc Natl Acad Sci USA, 93 (1996), pp. 2307-2311
[5.]
B. Littorin, G. Sundkvist, L. Nystrom, A. Carlson, M. Landin- Olsson, J. Ostman, et al.
Family chacaracteristics and life events before the onset of autoimmune type 1 diabetes in young adults.
Diabetes Care, 24 (2001), pp. 1033-1037
[6.]
T. Kimpimäki, A. Kupila, A.M. Hämäläinen, M. Kukko, P. Kumala, K. Savola, et al.
The first signs of beta-cells autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish type 1 diabetes prediction and prevention study.
J Clin Endocrinol Metab, 86 (2001), pp. 4782-4788
[7.]
Group EURODIAB ACE Study.
Variation and trends in incidence of chilhood diabetes in Europe.
Lancet, 355 (2000), pp. 873-876
[8.]
J.P. López-Siguero, A. Del Pino de la Fuente, M.J. Martínez-Aedo, J.A. Moreno-Molina.
Increased incidence of type 1 diabetes in the south of Spain.
Diabetes Care, 25 (2002), pp. 1099
[9.]
A. Imagawa, T. Hanafusa, J. Miyagawa, Y. Matsuzawa.
A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies.
N Engl J Med, 342 (2000), pp. 301-307
[10.]
S. Tanaka, T. Kobayashi, T. Mornotsu.
Anovel subtype of type 1 diabetes mellitus.
N Engl J Med, 342 (2000), pp. 1835-1837
[11.]
G.R. Vreugdenhil, N.C. Schloot, A. Hoorens, C. Rongen, D.G. Pipeleers, W.J. Melchers, et al.
acute onset of type 1 diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways.
Clin Infect Dis, 31 (2000), pp. 1025-1031
[12.]
G. Carreras, D. Mauricio, A. Pérez, A. De Leiva.
Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetics patients?.
Diabetes Care, 23 (2000), pp. 1715-1716
[13.]
S. Tanaka, T. Kobayashi, K. Nakanishi, R. Koyama, M. Okubo, T. Murase, et al.
Association of HLA-DQ genotype in autoantibody- negative and rapid onset type 1 diabetes.
Diabetes Care, 25 (2002), pp. 2302-2307
[14.]
R.R. Wing, E.H. Blair, P. Bononi, M.D. Marcus, R. Watanabe, R.N. Bergman.
Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients.
Diabetes Care, 17 (1994), pp. 30-36
[15.]
G.E. Umpierrez, M.M.C. Casals, S.S.P. Gebhart, P.S. Mizon, L.S. Clark WS Phillips.
Diabetic ketoacidosis in obese African- Americans.
Diabetes, 44 (1995), pp. 79-85
[16.]
A.L. Rosenbloom, J.R. Joe, R.S. Young, W.E. Winter.
Emerginig epidemic of type 2 diabetes in youth.
Diabetes Care, 22 (1999), pp. 345-354
[17.]
S.S. Fajans, G.I. Bell, K.S. Polonsky.
Molecular mechanisms and clinical phatophysiology of maturity-onset diabetes of the young.
N Engl J Med, 27 (2001), pp. 971-980
[18.]
R. Barrio, C. Mellamé-Chantelot, J.C. Moreno, V. Morel, H. Calle, M. Alonso.
Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families.
J Clin Endocrinol Metab, 87 (2002), pp. 2532-2539
[19.]
K. Yagamata, H. Furuta, N. Oda.
Mutations in the hepatocyte nuclear factor-4 alfa gene in maturity-onset diabetes of the young (MODY 1).
Nature, 384 (1996), pp. 458-460
[20.]
P. Froguel, H. Zouali, N. Vinnet.
Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus.
N Engl J Med, 328 (1993), pp. 697-702
[21.]
K. Yamagata, N. Oda, P.J. Kaisaki.
Mutations in the hepatocyte nuclear factor-1 alfa gene maturity onset diabetes of the young (MODY 3).
Nature, 384 (1996), pp. 455-458
[22.]
L. Bjokaug, J.V. Sagen, P. Thorsby, O. Sovik, A. Molven, P.R. Njolstad.
Hepatocyte nuclear factor-1 alfa gene mutations and diabetes in Norway.
J Clin Endocrinol Metab, (2003), pp. 920-931
[23.]
D.A. Stoffers, J. Ferrer, W.L. Clarke, J.F. Habener.
Early-onset type-II diabetes mellitus (MODY 4) linked to IPF1.
Nat Genet, 17 (1997), pp. 384-385
[24.]
Y. Horikawa, H. Iwasaki, M. Hara.
Mutation in hepatocyte nuclear factor 1-beta gene (TFC2) associated with MODY.
Nat Genet, 17 (1997), pp. 384-385
[25.]
M.T. Malecki, U.S. Jhala, A. Antonellis.
Mutations in NEUROD1 are associated wiiith the development of type 2 diabetes mellitus.
Nat Genet, 23 (1999), pp. 323-328
[26.]
T. Kadowaki, H. Kadowaki, Y. Mori, K. Tobe, R. Sakuta, Y. Suzuki, et al.
A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA.
N Engl J Med, 330 (1994), pp. 962-968
[27.]
D.C. Robbins, S.E. Schoelson, A.H. Rubenstein, H.S. Tafer.
Familial hyperproinsulinemia: two cohorts secreting indistinguishable type II intermediates of proinsulin conversion.
J Clin Invest, 73 (1984), pp. 714-719
[28.]
B.D. Given, M.E. Mako, H.S. Tager, D. Baldwin, J. Markese, A.H. Rubenstein, et al.
Diabetes due to secretion of an abnormal insulin.
N Engl J Med, 302 (1980), pp. 129-135
[29.]
C.S. Yajnik, K.M. Sheldikar, S.S. Naik, S.V. Kanitkar, H. Orskov, K.G.M.M. Alberti, et al.
The ketoacidosis-resistance in fibrocalculous- pancreatic-diabetes.
Diabetes Res Clin Pract, 15 (1992), pp. 149-156
[30.]
M. Berelowitz, H.G. Eugene.
Non-insulin dependent diabetes mellitus secondary to other endocrine disorders.
Diabetes mellitus, pp. 496-502
[31.]
M.D. Esposti, A. Ngo, M.A. Myers.
Inhibition of mitochondrial complex I may account for IDDM induced by intoxication with rodenticide Vacor.
Diabetes, 45 (1996), pp. 1531-1534
[32.]
M. Solimena, R. Folli, Aparisi, G. Pozza, P. De Camilli.
Autoantibodies to GABA-nergic neurons and pancreatic beta cells in stiffman síndrome.
N Engl J Med, 41 (1992), pp. 347-353
[33.]
B.E. Metzger, Committee Organizing.
Summary and recommendations of the Third International Workshop-Conference on Gestational Diabetes Mellitus.
Diabetes, 40 (1991), pp. 197-201
[34.]
Mellitus The Expert Committee on the Diagnosis and Classification of Diabetes.
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
Diabetes Care, 20 (1997), pp. 1183-1197
[35.]
The Expert Committe on the Diagnosis and Classification of Diabetes Mellitus.
Diabetes Care, 26 (2003), pp. 5-20
[36.]
M.M. Gabir, R.L. Hanson, D. Dabelea, G. Imperatore, J. Roumain, P.H. Bennett.
The 1997 American Diabetes Association and 1999 World Health Organization Criteria for hyperglycemia in the diagnosis and prediction of diabetes.
Diabetes Care, 23 (2000), pp. 1108-1112
[37.]
B.L. Somani, S.S. Bangar, R. Bhalwar.
American Diabetes Association criteria for diabetes diagnosis.
Diabetes Care, 22 (1999), pp. 366
[38.]
E. Mannucci, A. De Bellis, A.M. Cernigoi, C. Tortul, C.M. Rotella, M. Velussi, et al.
Further data on the comparison between World Health Organization and American Diabetes Association diagnostic criteria.
Diabetes Care, 22 (1999), pp. 1755-1756
[39.]
World Health Organization.
Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation.
Part 1. Diagnosis and classification of diabetes mellitus,
[40.]
Association American Diabetes.
Tests of glycemia in diabetes (Position Statement).
Diabetes Care, 26 (2003), pp. 106-108
[41.]
Association American Diabetes.
Standards of medical cares for patients with diabetes mellitus (Position Statement).
Diabetes Care, 26 (2003), pp. 33-50
[42.]
M. Mayrhofer, D.U. Rabin, L. Messenger, E. Standl, A.G. Ziegler.
Value of ICA 512 antibodies for prediction and diagnosis of type 1 diabetes.
Exp Clin Endocrinol Diab, 104 (1996), pp. 228-234
[43.]
J.P. Krischer, D.D. Cuthbertson, L. Yu, T. Oraban, N. MacLaren, R. Jackson, et al.
Screening strategies for the identificartion of multiple antibody-positive relatives of individuals with type 1 diabetes.
J Endocrinol Metab, 88 (2003), pp. 103-108
[44.]
T. Kimpimäki, P. Kulmala, K. Savola, A. Kupila, S. Korhonen, T. Simell.
Natural history of beta-cell autoinmunity ub young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.
J Clin Endocrinol Metab, 87 (2002), pp. 4572-4579
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados